Press release
Lung Transplant Rejection (Immunology) Pipeline Landscape Report, H1, 2017 - Pharmaceutical Disease Pipeline Guide
Market Research Hub
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1107568
Lung transplantation is the therapy used in various lung diseases. Lung transplant replaces an injured or diseased lung with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted lung as foreign and may work against it. Patients may hence develop complications and eventually reject the new organ.
Immunosuppressive drugs are administered simultaneously which prevent the body from either identifying or attacking the foreign organ via various immune responses thus blocking organ rejection and facilitating a successful transplant.
The Lung Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Lung Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 3, 1, 4 and 1 respectively.
Lung Transplant Rejection (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Lung Transplant Rejection (Immunology).
- The pipeline guide reviews pipeline therapeutics for Lung Transplant Rejection (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Lung Transplant Rejection (Immunology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Lung Transplant Rejection (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Lung Transplant Rejection (Immunology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Lung Transplant Rejection (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Lung Transplant Rejection (Immunology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/lung-transplant-rejection-pipeline-review-h1-2017-report.html
Table of Contents:
Table of Contents 2
Introduction 6
Lung Transplant Rejection - Overview 7
Lung Transplant Rejection - Therapeutics Development 8
Lung Transplant Rejection - Therapeutics Assessment 24
Lung Transplant Rejection - Companies Involved in Therapeutics Development 38
Lung Transplant Rejection - Drug Profiles 78
Lung Transplant Rejection - Dormant Projects 379
Lung Transplant Rejection - Discontinued Products 384
Lung Transplant Rejection - Product Development Milestones 386
Appendix 395
List of Tables
Number of Products under Development for Lung Transplant Rejection, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub/
LinkedIn: https://www.linkedin.com/company/market-research-hub/
Facebook: https://www.facebook.com/MarketResearchHub/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Transplant Rejection (Immunology) Pipeline Landscape Report, H1, 2017 - Pharmaceutical Disease Pipeline Guide here
News-ID: 562299 • Views: …
More Releases from Market Research Provider - MRH
Global Sports Accessories Market Status & Growth Analysis Forecasted till 2022
Market Research Hub (MRH) has included a new report titled “Global Sports Accessories Market Research Report 2017”, to its huge database. This research study includes information about the regional production along with revenue and market share. The report further updates that the sports market on the global level would acquire a rise at a positive CAGR during the period 2017-2022, which is surely a major boost for the concerned sector.…
Global Film Release Liners Market to Rise at an Impressive Rate during the Forec …
The demand for film release liners is greatly influenced by the advancements in the packaging industry. The increased preference for modern and latest packaging all across the world, coupled with the increasing investments in the pharmaceuticals and the food and beverages industries, is expected to drive the demand in the global market for film release liners over the coming years. A new market report with a title “Global Film Release…
Global Coated Graphite Market Status, Trends & Future Outlook until 2022
The latest research report added to the vast database of Market Research Hub (MRH). The study is titled “Global Coated Graphite Market Research Report 2017”, which includes information about the regional segmentation on the basis of factors such as production, consumption, revenue, and market share. It is also mentioned that the market would soon acquire growth at a double-digit CAGR between 2017 and 2022.
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1217172
Geographically, this…
More Releases for Lung
Lung Cancer Surgery Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Lung Cancer Surgery Market: Global Opportunity Analysis and Industry Forecast 2020-2027’.
This market research study determines the increase in changes and the aspects which are likely to have an impact on the growth of the Lung Cancer Surgery Market. Increased demand for the technologies is also one of the factors, which are likely to boost the growth of this industry. The…
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor…
Higher carcinoma lung population dominates the lung cancer therapeutics market
Lung cancer is a malignant lung tumor, which is characterized by uncontrolled division and growth of cells in the lungs. The ability of lungs to provide oxygen into the bloodstream decreases with increasing size of tumor. The lung carcinoma is classified as, non-small cell and small cell lung cancer and originates from the epithelial cells. Lung cancer has the highest mortality rate globally, where exposure to asbestos, cigarette and pipe…
Lung Management Products Market Soaring Demand Assures Motivated Revenue Share d …
Lung management products are required for patients dealing with severe conditions such as asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and lung cancers. Lung management products are also used as a home-based care to exercise lungs and keep them healthy for a longer run. Several lung exercisers are available and being highly preferred. According to the American Lung Association, lung cancer was the most common cancer type in 2015…
Artificial Lung Market Key Players 2018 - Haemair Ltd, Lung Biotechnology PBC, a …
Artificial Lung
Overview:
Medical Devices sector report, “Artificial Lung - Medical Devices Pipeline Assessment, 2018" provides an overview of Artificial Lung currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.
The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start…
Lung Cancer Vaccine Market Lung Cancer Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
What are Cancer Vaccines?
Mechanism of Cancer Vaccines
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism
Overview of Lung Cancer Proliferation
3.1 Lung Cancer Invasion
3.1.1 Transformation of Normal Cell into…
